<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02590081</url>
  </required_header>
  <id_info>
    <org_study_id>NMRR-14-950-20443</org_study_id>
    <nct_id>NCT02590081</nct_id>
  </id_info>
  <brief_title>Effect of Sodium Rinsing Fluid on Blood Pressure and Interdialytic Weight Change in Hemodialysis Patients</brief_title>
  <acronym>NSD5</acronym>
  <official_title>A Prospective Randomized, Double-Blind Parallel Group Trial To Assess The Efficacy And Safety Of Intravenous Dextrose 5% Solution Compare With Normal Saline (Standard Care) In Rinsing During Haemodialysis In Subjects With End Stage Renal Failure (ESRF) With Respect To Systolic Blood Pressure Control Over 3 Months Period.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Penang Hospital, Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Malaysia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Penang Hospital, Malaysia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, double-blind, parallel group trial to assess the efficacy
      and safety of intravenous dextrose 5% solution compare with normal saline (standard care) in
      wash back procedure during haemodialysis in patients with end stage renal failure (ESRF) with
      respect to systolic blood pressure control over 3 months period.

      The primary objective is to establish efficacy of 5% dextrose solution compared with normal
      saline (0.9% sodium chloride solution) with respect to systolic blood pressure control in
      subjects with end stage renal failure (ESRF) on regular hemodialysis. Secondary objectives
      include monitoring the change in body weight, thirst level and body fluid volume.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>systolic blood pressure control</measure>
    <time_frame>Time from week 0 until week 12</time_frame>
    <description>post intervention systolic blood pressure reduction compared to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Interdialytic weight gain</measure>
    <time_frame>Time from week 0 until week 12</time_frame>
    <description>reduced Interdialytic weight gain in experimental group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>thirst level</measure>
    <time_frame>Time from week 0 and week 12</time_frame>
    <description>Dialysis thirst inventory questionnaire to be administer by patient at baseline (week 0) and end of trial (week 12)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intradialytic event</measure>
    <time_frame>Time from week 0 until week 12</time_frame>
    <description>Any incident occuring during hemodialysis treatment which needed medical intervention. The event are chills and rigor, chest pain, giddiness, cramps, vomiting, blood loss and hypotension.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>adverse events</measure>
    <time_frame>Time from week 0 until week 12</time_frame>
    <description>All observed or spontaneously reported adverse events occur during the trial period.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">434</enrollment>
  <condition>End-Stage Kidney Disease</condition>
  <condition>Hemodialysis</condition>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Normal saline will be used for wash back procedure at the end of hemodiaysis.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>dextrose 5%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dextrose 5% will be used for wash back procedure at the end of hemodiaysis.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dextrose 5%</intervention_name>
    <arm_group_label>dextrose 5%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory, clinically stable maintenance HD patients on a thrice weekly HD regime.

          -  Have regular hemodialysisforat least 6 months or more.

          -  Willing and able to provide written, signed informed consent after the nature of the
             study has been explained.

          -  Willing and able to comply with all study procedures.

          -  Age â‰¥18 years; Age &lt; 75 years old

        Exclusion Criteria:

          -  Diabetes mellitus, Malignancy, Pregnancy

          -  Inability or unwillingness to provide written consent.

          -  Inability or unwillingness to comply with the requirements of the protocol as
             determined by the investigator.

          -  Simultaneous participation in another clinical study except observational trials

          -  Any psychological condition which could interfere with the patient's ability to comply
             with the study protocol

          -  Inability to perform a blood pressure measurement on the upper limb

          -  Scheduled for living donor kidney transplant, change to peritoneal dialysis, home HD
             or plans to relocate to another center during the study period.

          -  Life expectancy &lt; 6 months

          -  Recent acute myocardial infarction, congestive cardiac failure, stroke, angina or ICU
             admission within last 6 months,

          -  Planned to migrate/move out of the city

          -  Alcohol abuse/ drug abuse within last 6 months

          -  Missed &gt; 2 hemodialysis sessions over 1 month

          -  Requiring non- cuff catheter for hemodialysis

          -  Admitted for major infection within the last one month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Loke Meng Ong, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Penang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Loke Meng Ong, FRCP</last_name>
    <phone>+60-04-2225333</phone>
    <phone_ext>5767</phone_ext>
    <email>onglokemeng@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Sultanah Bahiyah, Alor Setar</name>
      <address>
        <city>Alor Setar</city>
        <state>Kedah</state>
        <zip>05460</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chen Hua Ching, MRCP</last_name>
      <phone>+60-04-7496898</phone>
      <email>nchching@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Tuanku Jaafar</name>
      <address>
        <city>Seremban</city>
        <state>Negeri Sembilan</state>
        <zip>70300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lily Mushahar, M.Med</last_name>
      <phone>+60 6-7684000</phone>
      <email>lilymushahar@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Tengku Ampuan Afzan</name>
      <address>
        <city>Kuantan</city>
        <state>Pahang</state>
        <zip>25100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mohd Ramli Seman, M.Med</last_name>
      <phone>+60-09-5572222</phone>
      <email>mohdramliseman9@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Balik Pulau</name>
      <address>
        <city>Balik Pulau</city>
        <state>Penang</state>
        <zip>11000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Loke Meng Ong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Bukit Mertajam</name>
      <address>
        <city>Bukit Mertajam</city>
        <state>Penang</state>
        <zip>14000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anita Bhajan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penang Hospital</name>
      <address>
        <city>George Town</city>
        <state>Penang</state>
        <zip>10990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ong Loke Meng, FRCS</last_name>
      <phone>00 604 2225333</phone>
      <phone_ext>5767</phone_ext>
      <email>onglokemeng@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Kepala Batas</name>
      <address>
        <city>Kepala Batas</city>
        <state>Penang</state>
        <zip>13200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anita Bhajan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seberang Jaya Hospital</name>
      <address>
        <city>Seberang Jaya</city>
        <state>Penang</state>
        <zip>13700</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anita Bhajan</last_name>
      <phone>+60-04-3827496</phone>
      <email>abmanocha1518@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Sungai Bakap</name>
      <address>
        <city>Sungai Bakap</city>
        <state>Penang</state>
        <zip>14200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anita Bhajan</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Miri Hospital</name>
      <address>
        <city>Miri</city>
        <state>Sarawak</state>
        <zip>98000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keng Hee Koh, MRCP(UK)</last_name>
      <phone>+60-85-420033</phone>
      <email>kohkenghee@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Selayang Hospital</name>
      <address>
        <city>Selayang</city>
        <state>Selangor</state>
        <zip>68100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hin Seng Wong, FRCP</last_name>
      <phone>+60-03-61367788</phone>
      <email>hinseng@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Serdang</name>
      <address>
        <city>Serdang</city>
        <state>Selangor</state>
        <zip>43400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bak Leong Goh, FRCP</last_name>
      <phone>+60-03-89475555</phone>
      <email>bak.leong@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UKM Medical Centre</name>
      <address>
        <city>Cheras</city>
        <state>Wilayah persekutuan Kuala lumpur</state>
        <zip>56000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Abdul Halim Abdul Gafor, M.Med</last_name>
      <phone>+60-03-91456074</phone>
      <email>halimgafor@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan Kuala Lumpur</state>
        <zip>50586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ghazali Ahmad Kutty, M.Med</last_name>
      <phone>+60-03-26155380</phone>
      <email>ghazaliahmad@moh.gov.my</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UM Medical Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan Kuala Lumpur</state>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Soo Kun Lim</last_name>
      <phone>+60-0379492497</phone>
      <email>sookun_73@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <reference>
    <citation>Agarwal R. Epidemiology of interdialytic ambulatory hypertension and the role of volume excess. Am J Nephrol. 2011;34(4):381-90. doi: 10.1159/000331067. Epub 2011 Sep 2.</citation>
    <PMID>21893975</PMID>
  </reference>
  <reference>
    <citation>Brennan JM, Ronan A, Goonewardena S, Blair JE, Hammes M, Shah D, Vasaiwala S, Kirkpatrick JN, Spencer KT. Handcarried ultrasound measurement of the inferior vena cava for assessment of intravascular volume status in the outpatient hemodialysis clinic. Clin J Am Soc Nephrol. 2006 Jul;1(4):749-53. Epub 2006 May 24.</citation>
    <PMID>17699282</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 27, 2015</study_first_submitted>
  <study_first_submitted_qc>October 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 28, 2015</study_first_posted>
  <last_update_submitted>October 27, 2015</last_update_submitted>
  <last_update_submitted_qc>October 27, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Penang Hospital, Malaysia</investigator_affiliation>
    <investigator_full_name>Dr.Ong Loke Meng</investigator_full_name>
    <investigator_title>doctor</investigator_title>
  </responsible_party>
  <keyword>Normal saline</keyword>
  <keyword>Destrose 5%</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Interdialytic weight gain</keyword>
  <keyword>thirst level</keyword>
  <keyword>End Stage Renal Failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

